Dr. Amer Malik, MD

NPI: 1679560684
Total Payments
$9,292
2024 Payments
$781.74
Companies
36
Transactions
481
Medicare Patients
1,323
Medicare Billing
$126,306

Payment Breakdown by Category

Food & Beverage$9,242 (99.5%)
Gifts$49.99 (0.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $9,242 478 99.5%
Gift $49.99 3 0.5%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $3,148 178 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $1,005 45 $0 (2024)
Janssen Biotech, Inc. $978.97 45 $0 (2024)
NESTLE HEALTHCARE NUTRITION INC. $718.91 30 $0 (2023)
PFIZER INC. $539.30 30 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $477.26 26 $0 (2024)
Celgene Corporation $322.39 16 $0 (2024)
IRONWOOD PHARMACEUTICALS, INC $284.31 15 $0 (2024)
Gilead Sciences, Inc. $254.94 8 $0 (2024)
Merck Sharp & Dohme LLC $154.73 10 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $781.74 36 Takeda Pharmaceuticals U.S.A., Inc. ($138.71)
2023 $1,616 79 ABBVIE INC. ($309.32)
2022 $1,285 64 ABBVIE INC. ($492.97)
2021 $1,443 74 AbbVie Inc. ($659.94)
2020 $812.50 43 AbbVie Inc. ($377.73)
2019 $986.87 50 Takeda Pharmaceuticals U.S.A., Inc. ($391.42)
2018 $1,104 65 AbbVie, Inc. ($365.04)
2017 $1,261 70 AbbVie, Inc. ($551.74)

All Payment Transactions

481 individual payment records from CMS Open Payments — Page 2 of 20

Date Company Product Nature Form Amount Type
02/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Food and Beverage In-kind items and services $24.32 General
02/07/2024 Janssen Biotech, Inc. STELARA (Biological) Food and Beverage In-kind items and services $21.99 General
Category: Immunology
02/07/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $17.29 General
Category: IMMUNOLOGY
02/02/2024 Takeda Pharmaceuticals U.S.A., Inc. GATTEX (Drug) Food and Beverage In-kind items and services $32.85 General
Category: INTERNAL MEDICINE
01/23/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $19.05 General
Category: INFLAMMATION AND IMMUNOLOGY
01/22/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $23.78 General
Category: INTERNAL MEDICINE
01/20/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $18.32 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
01/19/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $14.65 General
Category: Immunology
01/17/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $15.15 General
01/12/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $32.80 General
Category: Neuroscience
01/10/2024 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug) Food and Beverage Cash or cash equivalent $13.73 General
Category: GI
12/19/2023 ABBVIE INC. CREON (Drug), LINZESS Food and Beverage In-kind items and services $17.50 General
Category: ENDOCRINOLOGY
12/11/2023 Salix Pharmaceuticals, a division of Bausch Health US, LLC TRULANCE (Drug) Food and Beverage In-kind items and services $24.61 General
Category: Gastroenterology
12/11/2023 PFIZER INC. XELJANZ (Drug), COMIRNATY, VELSIPITY Food and Beverage In-kind items and services $19.35 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
12/05/2023 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $33.31 General
Category: Neuroscience
11/28/2023 Ferring Pharmaceuticals Inc. REBYOTA (Biological) Food and Beverage In-kind items and services $19.16 General
Category: GASTROENTEROLOGY
11/14/2023 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $28.16 General
Category: Neuroscience
11/09/2023 Janssen Biotech, Inc. STELARA (Biological) Food and Beverage In-kind items and services $20.81 General
Category: Immunology
11/07/2023 Gilead Sciences, Inc. Food and Beverage In-kind items and services $19.12 General
10/31/2023 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $25.40 General
Category: IMMUNOLOGY
10/30/2023 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $23.78 General
Category: INTERNAL MEDICINE
10/24/2023 Janssen Biotech, Inc. STELARA (Biological) Food and Beverage In-kind items and services $22.90 General
Category: Immunology
10/24/2023 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $12.61 General
Category: Neuroscience
10/23/2023 AIMMUNE THERAPEUTICS, INC. VOWST (Biological) Food and Beverage In-kind items and services $24.37 General
Category: GI
10/23/2023 Ferring Pharmaceuticals Inc. REBYOTA (Biological) Food and Beverage In-kind items and services $16.33 General
Category: GASTROENTEROLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 11 401 423 $231,885 $37,302
2022 8 248 272 $139,789 $20,858
2021 9 327 361 $200,551 $33,281
2020 9 347 381 $227,171 $34,865
Total Patients
1,323
Total Services
1,437
Medicare Billing
$126,306
Procedure Codes
37

All Medicare Procedures & Services

37 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 43 43 $55,900 $8,771 15.7%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 63 63 $63,000 $6,612 10.5%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 64 65 $52,000 $4,395 8.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 25 37 $8,325 $3,729 44.8%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 31 31 $8,525 $3,589 42.1%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 26 27 $6,750 $2,824 41.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 32 39 $5,850 $2,637 45.1%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2023 14 14 $13,090 $1,746 13.3%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 25 25 $4,850 $1,578 32.5%
43235 Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 13 13 $8,645 $1,173 13.6%
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito Facility 2023 65 66 $4,950 $247.81 5.0%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 27 27 $32,272 $4,931 15.3%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 43 43 $42,350 $3,509 8.3%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 37 37 $31,000 $3,076 9.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 35 48 $7,228 $3,063 42.4%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2022 18 19 $15,995 $2,339 14.6%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 52 62 $5,624 $2,302 40.9%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 20 20 $4,120 $1,572 38.1%
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito Facility 2022 16 16 $1,200 $66.60 5.5%
45385 Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare Facility 2021 25 25 $27,450 $5,295 19.3%
43239 Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope Facility 2021 63 66 $56,496 $5,286 9.4%
45380 Biopsy of the large bowel using an endoscope (colonoscopy) Facility 2021 50 51 $49,674 $5,187 10.4%
45378 Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk Facility 2021 34 35 $28,595 $4,596 16.1%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 52 72 $10,872 $4,505 41.4%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 21 21 $8,799 $3,366 38.2%

About Dr. Amer Malik, MD

Dr. Amer Malik, MD is a Gastroenterology healthcare provider based in Riverside, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2005. The National Provider Identifier (NPI) number assigned to this provider is 1679560684.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amer Malik, MD has received a total of $9,292 in payments from pharmaceutical and medical device companies, with $781.74 received in 2024. These payments were reported across 481 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($9,242).

As a Medicare-enrolled provider, Malik has provided services to 1,323 Medicare beneficiaries, totaling 1,437 services with total Medicare billing of $126,306. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Location Riverside, RI
  • Active Since 10/04/2005
  • Last Updated 01/12/2026
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • NPI Number 1679560684

Products in Payments

  • STELARA (Biological) $945.94
  • ZENPEP (Drug) $718.91
  • LINZESS (Drug) $559.70
  • HUMIRA (Biological) $527.38
  • Creon (Drug) $499.32
  • ENTYVIO (Biological) $449.53
  • Humira (Biological) $404.79
  • Entyvio (Biological) $395.89
  • XIFAXAN (Drug) $367.44
  • ZEPOSIA (Drug) $307.04
  • XELJANZ (Drug) $293.05
  • MAVYRET (Drug) $288.93
  • Mavyret (Drug) $274.86
  • INFLECTRA (Biological) $246.25
  • CREON (Drug) $244.83
  • Linzess (Drug) $206.55
  • TRULANCE (Drug) $180.46
  • SKYRIZI (Biological) $127.53
  • VIBERZI (Drug) $124.48
  • Epclusa (Drug) $122.81

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Riverside